4547 — Kissei Pharmaceutical Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapNeutral

Annual cashflow statement for Kissei Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	16,507	13,680	14,449	15,610	16,891
Depreciation
Non-Cash Items	-18,120	-14,596	-10,320	-9,723	-20,040
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-584	-9,873	-10,061	-3,885	-2,980
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	1,533	-6,680	-1,678	6,617	-1,485
Capital Expenditures	-1,919	-2,547	-1,833	-5,030	-5,636
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	12,695	8,548	10,523	9,982	23,136
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	10,776	6,001	8,690	4,952	17,500
Financing Cash Flow Items	-2	-2	-1	-1	-1
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-2,756	-3,420	-10,006	-9,325	-10,255
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	9,557	-4,120	-2,997	2,271	5,812